SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Generate Biomedicines Reports $87.7 Million Q3 Loss, $404.2 Million in Cash

Generate Biomedicines reported third-quarter 2026 revenue of $4.2 million and a net loss of $87.7 million, compared with revenue of $9.6 million and a net loss of $60.0 million a year earlier. Cash, cash equivalents and marketable securities totaled $404.2 million at September 30, 2026. The company…

GENB

Related stories